{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:03:17Z","timestamp":1762506197436},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.juro.2013.10.073","type":"journal-article","created":{"date-parts":[[2013,10,26]],"date-time":"2013-10-26T07:30:34Z","timestamp":1382772634000},"page":"920-925","source":"Crossref","is-referenced-by-count":30,"title":["Validation of the Preoperative Plasma Fibrinogen Level as a Prognostic Factor in a European Cohort of Patients with Localized Upper Tract Urothelial Carcinoma"],"prefix":"10.1097","volume":"191","author":[{"given":"Martin","family":"Pichler","sequence":"first","affiliation":[{"name":"Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orietta","family":"Dalpiaz","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical University of Graz, Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg C.","family":"Ehrlich","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical University of Graz, Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Stojakovic","sequence":"additional","affiliation":[{"name":"Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica M.","family":"Mart\u00edn Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical University of Graz, Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Mannweiler","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Medical University of Graz, Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Pummer","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical University of Graz, Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Zigeuner","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical University of Graz, Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg C.","family":"Hutterer","sequence":"additional","affiliation":[{"name":"Department of Urology, Medical University of Graz, Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2013.10.073_bib1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.eururo.2010.12.042","article-title":"European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update","volume":"59","author":"Roupr\u00eat","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.10.073_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.juro.2013.10.073_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00345-012-0939-5","article-title":"Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma","volume":"31","author":"Fajkovic","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.juro.2013.10.073_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00345-012-1008-9","article-title":"A systematic review of the tools available for predicting survival and managing patients with urothelial carcinomas of the bladder and of the upper tract in a curative setting","volume":"31","author":"Drouin","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.juro.2013.10.073_bib5","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.juro.2012.10.057","article-title":"Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis","volume":"189","author":"Roupr\u00eat","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.10.073_bib6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.eururo.2009.11.035","article-title":"Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract","volume":"57","author":"Zigeuner","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.10.073_bib7","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.juro.2010.06.106","article-title":"Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study","volume":"184","author":"Seitz","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.10.073_bib8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.juro.2010.03.142","article-title":"Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract","volume":"184","author":"Margulis","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.10.073_bib9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/sj.bjc.6604926","article-title":"Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer","volume":"100","author":"Roxburgh","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.juro.2013.10.073_bib10","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.juro.2013.10.073_bib11","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/bjc.2013.28","article-title":"Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients","volume":"108","author":"Pichler","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.juro.2013.10.073_bib12","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/bjc.2013.443","article-title":"High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients","volume":"109","author":"Pichler","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.juro.2013.10.073_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1538-7836.2007.02808.x","article-title":"Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2)","volume":"6","author":"Sahni","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.juro.2013.10.073_bib14","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1634\/theoncologist.2009-0079","article-title":"Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study","volume":"14","author":"Polterauer","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.juro.2013.10.073_bib15","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/sj.bjc.6605547","article-title":"The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial","volume":"102","author":"Seebacher","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.juro.2013.10.073_bib16","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jso.21668","article-title":"High preoperative plasma fibrinogen levels are associated with distant metastases and impaired prognosis after curative resection in patients with colorectal cancer","volume":"102","author":"Tang","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.juro.2013.10.073_bib17","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1464-410X.2012.11353.x","article-title":"Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma","volume":"111","author":"Tanaka","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2013.10.073_bib18","doi-asserted-by":"crossref","unstructured":"International Union Against Cancer: Urological tumours: renal pelvis and ureter. In: TNM Classification of Malignant Tumours, 7th ed revised. Edited by LH Sobin, M Gospodarowicz and C\u00a0Wittekind. New York: Wiley-Liss Blackwell 2009; pp 258\u2013261.","DOI":"10.1002\/9780471420194.tnmc43.pub2"},{"key":"10.1016\/j.juro.2013.10.073_bib19","doi-asserted-by":"crossref","unstructured":"Dalpiaz O, Ehrlich GC, Mannweiler SM et\u00a0al: Validation of the pre-treatment neutrophil-lymphocyte ratio as prognostic factor in\u00a0a European cohort of patients with upper tract urothelial carcinoma. BJU Int 2013. Epub ahead of print.","DOI":"10.1111\/bju.12441"},{"key":"10.1016\/j.juro.2013.10.073_bib20","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.juro.2010.05.028","article-title":"Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma","volume":"184","author":"Ohno","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.10.073_bib21","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0895-4356(03)00207-5","article-title":"External validation is necessary in prediction research: a clinical example","volume":"56","author":"Bleeker","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.juro.2013.10.073_bib22","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1182\/blood.V96.10.3302","article-title":"Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells","volume":"96","author":"Palumbo","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.juro.2013.10.073_bib23","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1349-7006.2009.01115.x","article-title":"Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity","volume":"100","author":"Zheng","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.juro.2013.10.073_bib24","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1055\/s-0037-1613412","article-title":"Fibrinogen mediates bladder cancer cell migration in an ICAM-1-dependent pathway","volume":"89","author":"Roche","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.juro.2013.10.073_bib25","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1160\/TH11-04-0278","article-title":"The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis","volume":"106","author":"Tiedje","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.juro.2013.10.073_bib26","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.athoracsur.2006.01.032","article-title":"Preoperative serum fibrinogen level predicts postoperative pulmonary complications after lung cancer resection","volume":"81","author":"Song","year":"2006","journal-title":"Ann Thorac Surg"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002253471305756X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002253471305756X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2013.10.073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T03:30:21Z","timestamp":1651203021000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2013.10.073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["10.1016\/j.juro.2013.10.073"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2013.10.073","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}